Liam K. Harold
Dunedin, OTA, New Zealand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Dormancy regulon reduction was pivotal to the evolution of Mycobacterium tuberculosis.
Journal: Nature communications
Published: May 09, 2025
A dual-targeting succinate dehydrogenase and F1Fo-ATP synthase inhibitor rapidly sterilizes replicating and non-replicating Mycobacterium tuberculosis.
Journal: Cell chemical biology
Published: May 08, 2023
Beneficial modulation of human health in the oral cavity and beyond using bacteriocin-like inhibitory substance-producing streptococcal probiotics.
Journal: Frontiers in microbiology
Published: February 08, 2023
Interferon Gamma Response in Human Saliva Following Exposure to the Oral Probiotic Streptococcus salivarius BLIS K12.
Journal: Probiotics and antimicrobial proteins
Published: November 15, 2022
Deciphering functional redundancy and energetics of malate oxidation in mycobacteria.
Journal: The Journal of biological chemistry
Published: August 05, 2021
The cryo-EM structure of the bd oxidase from M. tuberculosis reveals a unique structural framework and enables rational drug design to combat TB.
Journal: Nature communications
Published: April 29, 2021
Transcriptional Inhibition of the F1F0-Type ATP Synthase Has Bactericidal Consequences on the Viability of Mycobacteria.
Journal: Antimicrobial agents and chemotherapy
Published: March 13, 2020
Antituberculosis Activity of the Antimalaria Cytochrome bcc Oxidase Inhibitor SCR0911.
Journal: ACS infectious diseases
Published: February 25, 2020
Two for the price of one: Attacking the energetic-metabolic hub of mycobacteria to produce new chemotherapeutic agents.
Journal: Progress in biophysics and molecular biology
Published: September 13, 2019
Last Updated: 09/26/2026